Abstract
In 2019, we published a Review on the relevance of gut microbial metabolites in obesity, non-alcoholic fatty liver disease and type 2 diabetes mellitus. Here, we highlight the importance of the balance between colonic proteolytic and saccharolytic metabolite production for metabolic health and the need to focus on more subgroup-based or personalized nutritional approaches.
Original language | English |
---|---|
Pages (from-to) | 613–614 |
Number of pages | 2 |
Journal | Nature Reviews Endocrinology |
Volume | 16 |
Issue number | 11 |
Early online date | 4 Sept 2020 |
DOIs | |
Publication status | Published - Nov 2020 |
Keywords
- DISTAL